The information that you provide us in this application and which you may provide us in the future may be used by Fisher Funds, the Supervisor and any related entities of either, your financial adviser or the distribution entity through which you joined the Scheme (if applicable) and by other service providers to the Scheme to provide services in relation to your investment and to promote to you other products and services. You have the right to access the information held by us and you may also request that it be corrected by contacting us. We will provide you (on request) with the name and address of any entity to which information has been disclosed.
The Australian Growth Fund gives you access to invest in quality, growing Australian businesses. The Australian market is deeper and broader than in New Zealand, which provides numerous opportunities to invest in great businesses. Being such a broad market with so many investment opportunities means some companies are often poorly researched and not well understood by the market. The outcome of this is that high quality companies can trade below their inherent value. Our team making investment decisions are well informed and spend their time conducting their own research on this market.
Why Australian shares?
There is a lot of diversity in the products and services that companies in the Australian market offer. Because of the population size,the growth path for Australian companies can be smoother than in New Zealand. This is important as it provides these companies a broader growth opportunity domestically, before they need to consider the challenging step of exporting their business model to chase growth.
Growth of $10,000 invested in the fund since inception
** S&P/ASX Small Industrials Index (Inception to 31/1/2012), S&P ASX 300 Industrials ex top 20 70% hedged to NZD (1/2/2012 - 31/3/2015), S&P/ASX 200 70% hedged (1/4/2015 to now)
In the portfolio holdings below you will find a diverse range of companies. Some of these will be brands you know well, and others may be new to you. The companies we invest in range from banks and fast food brands, to companies in the healthcare and tech sectors.
The Australian Growth Fund returned +4.5% (net) in June. This compares to a +2.6% return for the ASX 200 Index (70% hedged into NZ$).
Resmed’s (+20.8%) share price rose strongly as it stands to benefit from the problems encountered by its key competitor, Philips. Philips announced a recall of a key product used to treat sleep disordered breathing because the foam Philips uses in the product degrades and potentially impacts patients’ health. Resmed does not use the same foam in its devices. It therefore stands to gain market share in the near term as Resmed’s products will likely fill the void in the market created by the Philips recall.
Having risen strongly over the previous few months, the share prices of three of our Australian banks gave back some of this in June, with NAB (-2.7%), Westpac (-2.3%) and ANZ (-2.0%) all falling in the month. Gobally, financials had a softer month in equity markets. The Australian banks were also impacted by negative sentiment affiliated with broadening COVID related lockdowns across NSW and other states. The banks are well positioned to weather the negative impacts of these lockdowns.
Chart »
Apply Now »
Fees »
